Carriers of the variant allele in MDR1 intron 3 had ORs (95% CI) of 0.96 (0.72–1.29) for developing adenomas, and 0.70 (0.41–1.21) for developing colorectal cancer, respectively, compared to homozygous wild type carriers. Here, ABCB1 is linked to adenoma.